跳至主要内容
临床试验/NCT04648631
NCT04648631已完成不适用

The Microbiome of Hidradenitis Suppurativa (HS) Tunneling Wounds

University of Miami2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2021年2月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
2
主要终点
Change in Microbiome

研究概览

简要总结

The purpose of this study is to look at the change in the microbiome (bacterial composition) of an HS tunneling wound and examine if treatment with an antibiofilm surfactant wound gel (ABWG) (a topical medication that will fight bacteria attached to the surface of those tunnels) changes the bacterial composition of the wounds.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults 18 years old and older
  • Have diagnosis of HS confirmed by a dermatologist
  • Have at least one HS related tunneling wound that is at least 2 centimeters in length
  • Able to provide informed consent

排除标准

  • Individuals who are not yet adults
  • Women known to be pregnant
  • Subjects, who in the opinion of the PI, cannot comply with home application of the treatment.

结局指标

主要结局

Change in Microbiome

时间窗: Baseline, 4 weeks

As measured by quantitative 16s rDNA Polymerase Chain Reaction for bacterial enumeration from punch biopsy samples.

次要结局

  • Change in Lesion Severity as Measured by HS-PGA(Baseline, 4 week)
  • Change in Lesion Severity as Measured by the Hurley Stage(Baseline, 4 weeks)
  • Change in Pain as Measured by VAS(Baseline, 4 weeks)
  • Change HS Lesion Erythema(Baseline, 4 weeks)
  • Number of Participants With Decreased Pain Medication Use(4 weeks)
  • Change in Number of Days of Work/School Lost(Baseline, 4 weeks)
  • Change in Range of Motion(Baseline, 4 weeks)
  • Number of Dressings Used(4 weeks)
  • Number of Participants With Escalated Pain Medication Use(4 weeks)
  • Change in Exudate(Baseline, 4 weeks)
  • Change in Quality of Life as Measured by HiSQOL(Baseline, 4 weeks)
  • Change in Quality of Life as Measured by DLQI(Baseline, 4 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hadar Lev-Tov

Assistant Professor

University of Miami

研究点 (2)

Loading locations...

相似试验

Hidradenitis Suppurativa (HS) Tunneling Wounds | 临床试验